Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
1.180
+0.080 (7.27%)
Nov 18, 2024, 9:30 AM EST
Orgenesis Employees
Orgenesis had 146 employees as of December 31, 2023. The number of employees decreased by 21 or -12.57% compared to the previous year.
Employees
146
Change (1Y)
-21
Growth (1Y)
-12.57%
Revenue / Employee
$6,158
Profits / Employee
-$235,699
Market Cap
6.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Orgenesis News
- 5 days ago - Orgenesis GAAP EPS of $1.93, revenue of $0.3M - Seeking Alpha
- 2 months ago - Why Orgenesis (ORGS) Stock Is Down 23% Today - Benzinga
- 2 months ago - Orgenesis announces 1-for-10 reverse stock split to regain Nasdaq compliance - Seeking Alpha
- 2 months ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 3 months ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 6 months ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 7 months ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 7 months ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire